KCNN4 and ischemic stroke: KCa3.1 levels in the brain have been reported to increase during astrogliosis in a mouse model of ischemic stroke and genetic deletion of KCa3.1 reduced gliosis and neuronal loss in this mouse model (Wei et al., 2016).